325 Ellington Boulevard
Unit 317
Gaithersburg, MD 20878
United States
240 658 6710
https://www.bullfrogai.com
Sector(s): Healthcare
Industry: Health Information Services
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Vininder Singh | Founder, Chairman & CEO | 707.67k | N/A | 1970 |
Mr. Dane R. Saglio | Chief Financial Officer | 360k | N/A | 1958 |
Mr. J. T. Koffenberger | Chief Information Officer | N/A | N/A | N/A |
Hon. Thomas W. Chittenden X, DPHIL, Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Dr. Cetin Savkli Ph.D. | Chief AI Advisor & Member of Advisory Board | N/A | N/A | N/A |
Mr. William Hirschman | Chief Commercial Officer | N/A | N/A | N/A |
Dr. David P. Recker FACP, FACR, M.D. | Chief Medical Officer | N/A | N/A | 1958 |
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
Bullfrog AI Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.